The Royal Australian and New Zealand College of Psychiatrists (RANZCP), has today released a new Position Statement on ADHD care, calling for clinically led reform that expands access while ensuring safety, comprehensive assessment, and clear referral pathways for tāngata whai ora of all ages. 

ADHD has become a highprofile area of mental health, with growing public awareness and rising demand placing significant pressure on already stretched services.  

The Statement affirms that accurate diagnosis requires thorough evaluation and that stimulant prescribing must be based on diagnostic confidence, careful monitoring, and shared care arrangements. 

Dr Hiran Thabrew, Chair of Tū Te Akaaka Roa, the New Zealand National Office of the RANZCP said, “Tū Te Akaaka Roa supports easier and more equitable access to ADHD diagnosis and treatment for tāngata whai ora of all ages.  

“Given the current access barriers from psychiatry workforce shortages and increasing demand, we support a wider group of specialists being able to conduct comprehensive assessments and deliver holistic treatment after receiving adequate training. 

“While changes in regulation and management of ADHD-care are a welcome move to improve access to services, they must be matched with additional qualifications and training for healthcare professionals, development of practical implementation guidelines, adequate resourcing, separation of regulatory settings for young people and adults and clear referral pathways to specialists, so that standards of care are consistent across the motu.” 

The statement also highlights that while psychostimulants play a key role in ADHD management, they are not a standalone treatment.  

“Safe prescribing requires comprehensive assessment, ongoing monitoring, and integration with nonpharmacological psychosocial supports to ensure ADHD care is most effective,” Dr Thabrew said. 

“Any changes to the regulation of psychostimulants must consider the risks of medication use, abuse and diversion, and ensure provision of good clinical care.” 

“Without thorough evaluation, there’s a risk of missing mood and anxiety disorders, trauma related symptoms, autism or other neurodevelopmental needs, and substance use issues. These factors can completely change the diagnosis, require different treatment approaches, or make stimulant use unsafe,” Dr Thabrew said. 

“ADHD care must be safe, comprehensive and equitable. With robust governance, accredited training, and adequate resourcing, reforms can deliver consistent, highquality support for tāngata whai ora and their whānau across the motu.” 

The Position Statement, developed through extensive member input, provides guidance for safe and equitable ADHD care and a roadmap for governments. 

The full position statement can be found here: Safe, Comprehensive, and Equitable ADHD Care.

For media inquiries, please contact: Dishi Gahlowt on +61 437 315 911 or email media@ranzcp.org  

For all other expert mental health information visit Your Health in Mind, the RANZCP’s consumer health information website. 

The Royal Australian and New Zealand College of Psychiatrists is a membership organisation that prepares medical specialists in the field of psychiatry, supports and enhances clinical practice, advocates for people affected by mental illness and advises governments and other groups on mental health care. For information about our work, our members or our history, visit www.ranzcp.org. 

In Australia: If you or someone you know needs help, contact Lifeline on 13 11 14 or www.lifeline.org.au or the Suicide Callback Service on 1300 659 467 or www.suicidecallbackservice.org.au. 

In New Zealand: If you or someone you know needs help, contact Lifeline NZ on 0800 543 354 or www.lifeline.org.nz or the Suicide Crisis Helpline on 0508 828 865 or www.lifeline.org.nz/suicide-prevention.